title: Intranasal delivery of paroxetine nanoemulsion via the olfactory region for the management of depression: formulation, behavioural and biochemical estimation.
abstract: Paroxetine is a selective serotonin reuptake inhibitor (SSRI) and is used for the treatment of depression and anxiety problems, but suffers from the drawback of poor oral bioavailability (less than 50%) due to its extensive first pass metabolism. The objective of the present study was to develop a paroxetine loaded nanoemulsion (o/w type) for direct nose-to-brain delivery. Nanoemulsions were prepared by the spontaneous emulsification technique using Capmul MCM, Solutol HS 15 and propylene glycol as oil phase, surfactant and co-surfactant, respectively, for delivery of drug directly to the brain through the nasal route for better management of depression. Formulations were studied for droplet size, polydispersity index (PDI), percentage transmittance, refractive index, viscosity, zeta potential, surface morphology and in vitro permeation study. TEM images of optimized formulation showed spherical droplets with a mean diameter of 58.47 ± 3.02 nm, PDI of 0.339 ± 0.007 and zeta potential values of -33 mV. The formulation showed good results for transmittance (100.60 ± 0.577%), refractive index (1.412 ± 0.003) and viscosity (40.85 ± 6.40 cP). Permeation studies revealed a 2.57-fold enhancement in permeation as compared to the paroxetine suspension. Behavioural studies such as the forced swimming test and locomotor activity test were done on Wistar rats to study the antidepressant effect of the optimized formulation. Treatment of depressed rats with paroxetine nanoemulsion (administered intranasally) significantly improved the behavioural activities in comparison to paroxetine suspension (orally administered). Biochemical estimation results revealed that the prepared nanoemulsion was effective in enhancing the depressed levels of glutathione and decreasing the elevated levels of TBARS.
authors.affiliation: Department of Pharmaceutics, Faculty of Pharmacy, Jamia Hamdard (Hamdard University), Hamdard Nagar, New Delhi-110062, India.
authors.forename: Yogendra Raj
authors.initials: YR
authors.lastname: Pandey
authors.forename: Shobhit
authors.initials: S
authors.lastname: Kumar
authors.forename: Bijay Kumar
authors.initials: BK
authors.lastname: Gupta
authors.forename: Javed
authors.initials: J
authors.lastname: Ali
authors.forename: Sanjula
authors.initials: S
authors.lastname: Baboota
mesh_terms: D000281:Administration, Intranasal; D000818:Animals; D018687:Antidepressive Agents, Second-Generation / Q000008:administration & dosage* / Q000493:pharmacokinetics; D001522:Behavior, Animal / Q000187:drug effects*; D002626:Chemistry, Pharmaceutical / Q000379:methods; D003863:Depression / Q000188:drug therapy*; D004195:Disease Models, Animal; D004655:Emulsions; D005260:Female; D008297:Male; D017374:Paroxetine / Q000008:administration & dosage* / Q000494:pharmacology; D010316:Particle Size; D051381:Rats; D017208:Rats, Wistar; D013552:Swine
chemical_list: D018687:Antidepressive Agents, Second-Generation; D004655:Emulsions; D017374:Paroxetine